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Summary
Background: Although intraoperative transesophageal echocardiography (IOTEE) has
been widely used in cardiovascular surgery, the exact incidence of abnormalities
detected by IOTEE in each type of surgical procedure is still unclear. The aim of this
study was to review our experiences of IOTEE, in patients who underwent different
types of cardiovascular surgery and to evaluate the clinical usefulness of IOTEE.
Methods and results:Our database of 1011 consecutive patients, who underwent car-
diovascular surgery and IOTEE monitoring was reviewed. The incidence of abnormal
ﬁndings was 115 of 1011 patients (11.4%), and the highest incidence was the appear-
ance of new wall motion abnormalities after cardiopulmonary bypass. These ﬁndings
inﬂuenced surgical decision-making in 59 of the evaluated 1011 patients (5.8%).
∗ Corresponding author at: Division of Laboratory, Yamaguchi University Hospital, Ube 755-8505, Japan.
Tel.: +81 836 22 2676; fax: +81 836 22 2246.
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Conclusions: IOTEE provides important intraoperative and postoperative information
that may inﬂuence surgical decision-making in various cardiovascular surgeries.
e of Cardiology. Published by Elsevier Ireland Ltd. All rights
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racic aortic procedures (Fig. 1). A total of 115
of 1011 patients (11.4%) had abnormal ﬁndings
as listed in Table 1. The most frequent events© 2009 Japanese Colleg
reserved.
ntroduction
ntraoperative transesophageal echocardiography
IOTEE) has been widely used in cardiovascular
urgery and the favorable inﬂuence of IOTEE on
erioperative decision-making has been well rec-
gnized [1—4]. Before cardiac surgery, IOTEE can
eveal previously undiagnosed lesions and pathol-
gy, and allow immediate correction. Abnormal
ndings such as new left ventricular (LV) wall
otion abnormalities, residual valvular leakage,
nd aortic complications can be detected after
ardiopulmonary bypass (CPB). Although IOTEE has
een introduced during different types of cardiac
r aortic surgery and its usefulness has become
vident, the incidence of abnormalities that are
etected during the perioperative period by TEE
s unknown. The aim of this study was to review
ur experience of 1011 patients who underwent dif-
erent types of cardiac and thoracic aortic surgical
rocedures and to evaluate the clinical usefulness
f IOTEE.
ethods
e reviewed our departmental database for all
atients who underwent elective or urgent cardio-
ascular surgery in Yamaguchi University Hospital
nd who were monitored with IOTEE between Jan-
ary 1998 and December 2007. A large majority
f the IOTEE examinations were performed before,
uring, and after CPB. Informed consent, approved
y the institutional review board, was obtained
rom either all patients or their family members
efore surgery.
OTEE
multiplane TEE probe (5MHz) interfaced with
commercially available ultrasound scanner (SSD-
200, SSD-5500, or 5, ALOKA Ltd., Tokyo, Japan),
as inserted by cardiologists or anesthesiologists
fter the induction of general anesthesia. Images
ere obtained before sternotomy, before under-
oing CPB, after weaning from CPB, and when
arranted during the course of surgery. All images
ere recorded on S-VHS videotapes or digital video
w
i
t
Iiscs and stored on a digital database for off-
ine review and analysis. An electrocardiogram was
ecorded continuously throughout the procedure.
he IOTEE procedure was performed according to
he guidelines for perioperative TEE by the Amer-
can Society of Echocardiography (ASE) and the
ociety of Cardiovascular Anesthesiologists (SCA)
5,6]. The cardiologists who performed IOTEE dur-
ng the study had at least 3 years of TEE experience.
tudy design
efore, during, and after CPB, we evaluated the
ncidence of the events listed as follows: (1)
ppearance of a new wall motion abnormality; (2)
erigraft leakage after transluminal endovascular
tent graft repair; (3) intimal tears or ﬂaps of the
orta; (4) valve dysfunction; (5) difﬁculty in coming
ff CPB; and (6) other events.
esults
here was no failure of insertion of the TEE
robe in any patient. A total of 1079 patients
nderwent cardiac or thoracic aortic surgery, and
OTEE was performed in 1011 of these. There
as no complication related to manipulation of
he echo probe during IOTEE. IOTEE was per-
ormed in 360 patients who underwent coronary
rtery bypass graft surgery (CABG), 229 valve only
urgery (73 mitral valve, 109 aortic valve, and 47
ombined valve), 169 aorta replacement surgery,
6 transluminal endovascular stent graft repair,
9 combined procedure (39 combined valve-aorta
eplacement surgery, 24 combined CABG-valve
urgery, 14 combined valve-other procedure, 10
ombined CABG-aorta replacement surgery, 9
ombined CABG-other surgery, 3 combined valve-
ABG-aorta replacement-other surgery) and 88
atients undergoing miscellaneous cardiac or tho-ere occurrence of a new wall motion abnormal-
ty post-CPB, followed by perigraft leakage after
ransluminal endovascular stent graft repair. The
OTEE information inﬂuenced the cardiac surgical
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Table 1 Abnormal ﬁndings detected by intraoperative transesophageal echocardiography (115 ﬁndings).
Occurrence of a new wall motion abnormality 42 (4.2%)
Perigraft leakage after transluminal endovascular stent graft repair 16 (1.6%)
Intimal tears or ﬂaps of aorta 14 (1.4%)
Valve dysfunction 12 (1.2%)
Difﬁculty in weaning from cardiopulmonary bypass 6 (0.6%)
Other 25 (2.5%)
Table 2 Altered surgical management (59
alterations).
Additional aortic stenting 12 (20%)
Intra-aortic balloon pump/percutaneous
cardiopulmonary system insertion
11 (19%)
Vascular repair 8 (14%)
Valve repair 8 (14%)
Patients undergoing isolated CABG
New isolated regional wall motion abnormalities
were detected in 17 of 360 (4.7%) patients under-
going CABG-only surgery (Table 3). In 15 of 17
patients, wall motion abnormalities recovered dur-
ing close observation, and revision surgery on the
coronary artery bypass graft was performed in 2 of
the CABG patients (0.6%). After revision of surgery,
wall motion abnormality recovered in two cases.Revision of graft 6 (10%)
Other 14 (24%)
decision-making in 59 patients (5.8%) (Table 2). The
percentage of new events detected by IOTEE in
each surgical intervention is demonstrated in Fig. 2.
The number of events detected by IOTEE in each
cardiac or thoracic aortic procedure is listed in
Table 3. In all procedures, except for translumi-
nal endovascular stent graft repair, the appearance
of a new wall motion abnormality was detected
most frequently by IOTEE throughout the surgery. In
Fig. 3, the number of combined procedures is shown
for each year. Combined procedures such as CABG
and valve repair gradually increased for 10 years.
The year-related change of incidence of abnormal
ﬁndings is shown in Fig. 4. Between 1998 and 2005,
the ratio of abnormal ﬁndings gradually increased,
however in 2006 and 2007, the ratio decreased (4%).
Figure 1 Overview of surgical procedures in 1011
patients who had intraoperative transesophageal
echocardiography (IOTEE) performed during car-
diovascular surgery. CABG, coronary artery bypass
grafting.
Figure 2 The percentage of abnormal ﬁndings detected
by intraoperative transesophageal echocardiography
(IOTEE) in each surgical group. CABG, coronary artery
bypass grafting.
Figure 3 The number of patients who underwent com-
bined procedures in each year. Combined procedures such
as coronary artery bypass grafting and valve repair grad-
ually increased for 10 years.
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Figure 4 The number of intraoperative transesophageal
echocardiography (IOTEE) and percentages of abnormal
ﬁndings detected by IOTEE (yellow bar) in each year.
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aetween 1998 and 2005, the ratio of abnormal ﬁndings
radually increased. (For interpretation of the references
o color in this ﬁgure legend, the reader is referred to the
eb version of the article.)
atients undergoing aorta stent surgery
ransluminal endovascular stent graft repair was
erformed in 19 patients with distal aortic arch
neurysm, 21 patients with descending thoracic
ortic aneurysm, 25 patients with dissection of
he aorta (Stanford type B), and 1 patient with
ortic invasion of lung cancer. The percentage of
bnormal IOTEE ﬁndings in the aorta stent surgery
roup was 32%, and this was the highest among the
urgical groups (Fig. 2). The majority of new abnor-
alities were perigraft leakage from the stent graft
76% of abnormal ﬁndings in the aorta stent surgery
roup; Table 3, Fig. 5). Additional aortic stenting
as needed in 12 patients who underwent aorta
tent surgery.
atients undergoing valve surgery
itral valve-related procedure
total of 132 cases of mitral valve-related proce-
ures (73 mitral valve only, 19 mitral + aortic valve,
2 mitral + tricuspid valve, 9 mitral valve + CABG,
mitral valve + aorta, 2 mitral + aortic + tricuspid
alves) were performed. In six patients, infor-
ation obtained from IOTEE resulted in a return
o CPB after initial weaning from CPB. Severe
itral regurgitation was still present after mitral
alve repair, and additional repair or mitral valve
eplacement was performed. In one patient,
lthough severe mitral regurgitation was detected
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Figure 5 Perigraft leakage was observed immediately
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rafter deployment of stent graft in thoracic aortic
aneurysm. After 20—30min observation, thrombus for-
mation was observed in the aneurysm and the leakage
disappeared.
after CPB, systolic anterior motion of the mitral
anterior leaﬂet (SAM) after CPB was revealed. This
mitral regurgitation was thought to be caused by
obstruction of the LV outﬂow tract (Fig. 6a) induced
by the small chamber size of the LV, tachycardia,
and LV hyperkinetic wall motion. In this case,
after stopping infusion of the inotropic agent and
increasing LV volume, severe mitral regurgita-
tion disappeared as improving tachycardia and
obstruction of the LV outﬂow tract (Fig. 6b).
Aortic valve, combined valve procedure
Although the most frequent abnormal ﬁndings
detected by IOTEE during aortic or combined valve
procedure were newwall motion abnormalities, the
incidence was less than in mitral valve procedures
(Table 3).Discussion
We evaluated the clinical utility of IOTEE by review-
ing our experience of a series of 1011 patients
p
1
w
p
Figure 6 (a) Severe mitral regurgitation (arrow head) and obs
color ﬂow (arrow) detected by intraoperative transesophagea
ventricular outﬂow tract improved after volume loading and
disappeared. AAo, ascending aorta; LA, left atrium; LV, left vC. Kihara et al.
ho underwent different types of cardiac and
horacic aortic surgical procedures. In this study,
e demonstrated that TEE before and during
urgery inﬂuenced surgical decision-making in 59
f the 1011 patients (5.8%) evaluated (Table 2).
previously published large-scale study in 12,566
atients, reported that the pre- and post-CPB TEE
xaminations inﬂuenced surgical decision-making
n 7.0 and 2.2% of cases, respectively [7]. Although
e did not evaluate pre- and post-CPB separately,
he incidence of IOTEE ﬁndings that inﬂuenced
he surgical decision-making was comparable to
he data provided by Eltzschig et al. [7]. In
ur study, transluminal endovascular stent graft
epair surgery accounted for 6.5% of all surgeries.
lthough a few studies have been reported concern-
ng the usefulness of IOTEE in aorta stent surgery
or an aortic aneurysm or aortic dissection [8], the
ncidence of abnormal IOTEE ﬁndings in this type
f surgery was found to be the highest among the
urgical groups (Fig. 5). In contrast to open cardio-
ortic surgery, endovascular stent graft repair
urgery is often performed percutaneously and sur-
eons cannot view the operative ﬁeld directly.
ecause TEE is the only feasible method for visu-
lizing the aortic arch and the thoracic descending
orta as well as the position of the stent graft
ntraoperatively, IOTEE should be an essential mon-
toring device for transluminal endovascular stent
raft repair surgery. We performed IOTEE on almost
ll patients who underwent CABG. The routine use
f IOTEE during cardiac surgery remains controver-
ial, especially for lower risk patients scheduled
nly for CABG [9]. Previous studies reported that
evision of the graft was performed in 0.8% of
atients who underwent CABG [7,10]. In our study,
7 of 360 patients (5%) were found to have a new
all motion abnormality post-CPB. Most of these
atients did not need a return to CPB or an addi-
truction of the left ventricular outﬂow tract with mosaic
l echocardiography (IOTEE). (b) Obstruction of the left
stopping catecholamine, and then mitral regurgitation
entricle.
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ional graft, but needed observation for 20—30min,
hen wall motion abnormalities resolved. A revi-
ion of the previously placed graft was required in
wo cases (0.6%) and this percentage was compara-
le to the data reported previously [7,9]. Thus to
etect myocardial ischemia associated with possi-
le graft kinking, coronary spasm or air embolism,
OTEE is desirable in the patient who is undergoing
ABG. On the other hand, the necessity for IOTEE
n mitral valve surgery is established. According to
SE/SCA guidelines for performing a comprehen-
ive intraoperative multiplane TEE examination [6],
he use of IOTEE is strongly recommended for guid-
ng surgical decision-making by providing insight
nto the mechanism of mitral disease before repair
11]. IOTEE is useful for not only providing the
nformation before CPB, but also for detecting the
resence of residual regurgitation and its mecha-
ism after CPB. In our study, 7 of 132 cases who
nderwent mitral valve-related surgery had resid-
al mitral regurgitation detected, and 6 patients
eturned to CPB for additional repair. In one case,
evere mitral regurgitation with SAM was detected
mmediately after CPB (Fig. 6a). The incidence of
AM and LV outﬂow tract obstruction (LVOTO) were
eported to range from 2 to 16% [12—14], and was
ecognized to be not inconsiderable. In our case,
e thought that mitral regurgitation was attributed
o SAM and LVOTO, and then we loaded the LV
olume and stopped catecholamine, and mitral
egurgitation disappeared (Fig. 6b). Maslow et al.
14] reported that TEE analysis of the mitral valve
pparatus could identify patients likely to develop
AM/LVOTO after mitral valve repair for myxoma-
ous valve disease. According to their report, the
nterior leaﬂet length/posterior leaﬂet length con-
ributing to the mitral valve was signiﬁcantly lower
mong patients who developed SAM/LVOTO than
mong those who did not. Although these indices
ay be useful for predicting SAM/LVOTO before
PB, intraoperative monitoring by TEE is necessary
or evaluating mitral regurgitation during surgical
rocedures. Recently, real-time three-dimensional
3D) TEE was introduced into the clinical setting,
nd its usefulness for diagnosis of mitral valve
esions was reported [15—18]. Real-time 3D IOTEE
ill allow for the development of virtual surgi-
al programs and provide a means to assess mitral
esions in a circumferential direction and allow sur-
ical decision-making especially for mitral valve
rolapse. New technological developments in 3D
OTEE may take the place of 2D IOTEE in rou-
ine intraoperative monitoring for cardiovascular
urgery.
A previous study reported that the complications
ssociated with TEE were severe odynophagia, den-aphy 287
al injury, endotrachial tube malpositioning, upper
astrointestinal hemorrhage, esophageal perfora-
ion, and so on [19]. In our study, there was nomajor
omplication over 10 years. Because experienced
ardiologists operated the TEE probe carefully,
specially using a small probe (9mm in diameter),
e could overcome complications related to the
EE procedure.
onclusion
n our experience of 1011 cases who underwent
ntraoperative TEE, the incidence of abnormal ﬁnd-
ngs was 11.4%. These ﬁndings inﬂuenced surgical
ecision-making in 5.8% of all evaluated patients.
hus IOTEE provides valuable information to aid in
educing surgical complications and inﬂuences sur-
ical decision-making in a large variety of cardiac
r aortic surgical procedures.
cknowledgments
e appreciate the technical assistance of many
olleagues in performing echocardiographic record-
ng: Nobuaki Tanaka MD, Shiro Ono MD, Yasuaki
omochika MD, Takashi Tone MD, Aiko Muro MD,
ideki Kunichika MD, Takashi Fujino MD, Mitsuo
watate MD, Taketo Tanigawa MD, Kayo Omura MD,
akayuki Hisaoka MD, Kazumi Kimura MD, Nozomu
arada MD, Jinyao Liu MD, Yoko Sawa MD, Eizo Aka-
awa MD, and Ryo Hashimoto MD.
eferences
[1] Matsumoto M, Oka Y, Strom J, Frishman W, Kadish A,
Becker RM, Frater RW, Sonnenblick EH. Application of trans-
esophageal echocardiography to continuous intraoperative
monitoring of left ventricular performance. Am J Cardiol
1980;46:95—105.
[2] Beaupre PN, Kremer PF, Cahalan MK, Lurz FW, Schiller NB,
Hamilton WK. Intraoperative detection of changes in left
ventricular segmental wall motion by transesophageal two-
dimensional echocardiography. Am Heart J 1984;107(5 Pt
1):1021—3.
[3] Dubroff JM, Clark MB, Wong CY, Spotnitz AJ, Collins RH,
Spotnitz HM. Left ventricular ejection fraction during car-
diac surgery: a two-dimensional echocardiographic study.
Circulation 1983;68:95—103.
[4] Matsuzaki M, Toma Y, Kusukawa R. Clinical applica-
tions of transesophageal echocardiography. Circulation
1990;82:709—22.[5] Practice guidelines for perioperative transesophageal
echocardiography. A report by the American Society
of Anesthesiologists and the Society of Cardiovascular
Anesthesiologists Task Force on Transesophageal Echocar-
diography. Anesthesiology 1996;84:986—1006.
[[
[
[
[
[288
[6] Shanewise JS, Cheung AT, Aronson S, Stewart WJ, Weiss
RL, Mark JB, Savage RM, Sears-Rogan P, Mathew JP,
Quin˜ones MA, Cahalan MK, Savino JS. ASE/SCA guidelines
for performing a comprehensive intraoperative multiplane
transesophageal echocardiography examination: recom-
mendations of the American Society of Echocardiography
Council for Intraoperative Echocardiography and the Soci-
ety of Cardiovascular Anesthesiologists Task Force for
Certiﬁcation in Perioperative Transesophageal Echocardio-
graphy. J Am Soc Echocardiogr 1999;12:884—900.
[7] Eltzschig HK, Rosenberger P, Lofﬂer M, Fox JA, Aranki
SF, Shernan SK. Impact of intraoperative transesophageal
echocardiography on surgical decisions in 12,566
patients undergoing cardiac surgery. Ann Thorac Surg
2008;85:845—52.
[8] Abe S, Ono S, Murata K, Tomochika Y, Kimura K, Fujino T,
Ueda K, Tone T, Tanaka N, Takenaka H, Zempo N, Esato K,
Matsunaga N, Matsuzaki M. Usefulness of transesophageal
echocardiographic monitoring in transluminal endovascular
stent-graft repair for thoracic aortic aneurysm. Jpn Circ J
2000;64:960—4.
[9] Sutton DC, Kluger R. Intraoperative transesophageal
echocardiography: impact on adult cardiac surgery. Anaesth
Intensive Care 1998;26:287—93.
[10] Mishra M, Chauhan R, Sharma KK, Dhar A, Bhise M,
Dhole S, Omar A, Kasliwal RR, Trehan N. Real-time intra-
operative transesophageal echocardiography—–how useful?
Experience of 5,016 cases. J Cardiothorac Vasc Anesth
1998;12:625—32.
[11] Savage RM, Cosgrove DM. Systematic transesophageal
echocardiographic examination in mitral valve repair: the
evolution of a discipline into the twenty-ﬁrst century.
Anesth Analg 1999;88:1197—9.
[12] Jebara VA, Mihaileanu S, Acar C, Brizard C, Grare P,
Latremouille C, Chauvaud S, Fabiani JN, Deloche A, Car-
pentier A. Left ventricular outﬂow tract obstruction after
[
Available online at www.sC. Kihara et al.
mitral valve repair. Results of the sliding leaﬂet technique.
Circulation 1993;88(5 Pt 2):II30—4.
13] Lee KS, Stewart WJ, Lever HM, Underwood PL, Cosgrove
DM. Mechanism of outﬂow tract obstruction causing failed
mitral valve repair. Anterior displacement of leaﬂet coap-
tation. Circulation 1993;88(5 Pt 2):II24—9.
14] Maslow AD, Regan MM, Haering JM, Johnson RG, Levine
RA. Echocardiographic predictors of left ventricular out-
ﬂow tract obstruction and systolic anterior motion of the
mitral valve after mitral valve reconstruction for myxoma-
tous valve disease. J Am Coll Cardiol 1999;34:2096—104.
15] Watanabe N, Ogasawara Y, Yamaura Y, Kawamoto T, Toy-
ota E, Akasaka T, Yoshida K. Quantitation of mitral valve
tenting in ischemic mitral regurgitation by transthoracic
real-time three-dimensional echocardiography. J Am Coll
Cardiol 2005;45:763—9.
16] Sugeng L, Shernan SK, Weinert L, Shook D, Raman J,
Jeevanandam V, DuPont F, Fox J, Mor-Avi V, Lang RM. Real-
time 3D transesophageal echocardiography in valve disease:
comparison with surgical ﬁndings and evaluation of pros-
thetic valves. J Am Soc Echocardiogr 2008;21:1347—57.
17] Hirata K, Pulerwitz T, Sciacca R, Otsuka R, Oe Y, Fujikura
K, Oe H, Hozumi T, Yoshiyama M, Yoshikawa J, Di Tullio
M, Homma S. Clinical utility of new real time three-
dimensional transthoracic echocardiography in assessment
of mitral valve prolapse. Echocardiography 2008;25:
482—8.
18] Masaki N, Iwatsuka R, Nagahori W, Ohno M, Arakawa T,
Suzuki M, Matsumura A, Hashimoto Y. Thee-dimensional
echocardiography could distinguish a ventricular septal
defect adjacent to asymptomatic ruptured sinus of Valsalva
aneurysm. J Cardiol 2008;51:139—43.
19] Kallmeyer IJ, Collard CD, Fox JA, Body SC, Shernan SK.
The safety of intraoperative transesophageal echocardio-
graphy: a case series of 7200 cardiac surgical patients.
Anesth Analg 2001;92:1126—30.
ciencedirect.com
